(Q28596805)

inferred from title

author

Martine Reynaud-Gaubert

15

Martine Reynaud-Gaubert

0 references

Sylvain Marchand-Adam

12

Sylvain Marchand-Adam

0 references

Dominique Israel-Biet

10

Dominique Israel-Biet

0 references

Emmanuel Bergot

2

Emmanuel Bergot

0 references

Dominique Israel-Biet

Dominique Israel-Biet

10

0 references

Vincent Cottin

1

Vincent Cottin

0 references

Jacques Cadranel

4

Jacques Cadranel

0 references

Jean-François Cordier

19

Jean-François Cordier

0 references

author name string

Emmanuel Bergot

2

0 references

Arnaud Bourdin

3

0 references

Philippe Camus

5

0 references

Bruno Crestani

6

0 references

Jean-Charles Dalphin

7

0 references

Philippe Delaval

8

0 references

Claire Dromer

9

0 references

Romain Kessler

11

0 references

Charles Hugo Marquette

13

0 references

Grégoire Prévot

14

0 references

Martine Reynaud-Gaubert

15

0 references

Dominique Valeyre

16

0 references

Benoit Wallaert

17

0 references

Benoit Bouquillon

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

18

0 references

language of work or name

English

0 references

publication date

October 2015

0 references

1 reference

1

0 references

issue

2

0 references

page(s)

00032-2015

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Subclinical interstitial lung disease: why you should care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5005118

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27730153

12 December 2020

inferred from PubMed ID database lookup

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27730153

12 December 2020

inferred from PubMed ID database lookup

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27730153

12 December 2020